Summary & Overview
CPT 92986: Balloon Aortic Valvuloplasty, Percutaneous
CPT code 92986 represents percutaneous balloon aortic valvuloplasty, a minimally invasive procedure to dilate a stenotic aortic valve and improve blood flow. The code captures a therapeutic catheter-based intervention used in acute and palliative settings, and it remains relevant nationally for hospitals and interventional cardiology programs managing symptomatic aortic stenosis or as a bridge to definitive therapy.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find clinical context for the procedure, typical sites of service, and the operational implications for hospital and outpatient interventional suites. The publication outlines common modifiers and coding considerations, payer coverage patterns, and how CPT code 92986 fits within broader valvular intervention billing strategies.
This summary provides benchmarks for utilization and reimbursement patterns, highlights policy updates affecting coverage and prior authorization for transcatheter valve procedures, and explains how documentation and coding map to clinical workflows. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 92986 describes a balloon aortic valvuloplasty, a catheter-based procedure in which a provider opens a stenotic aortic valve using a balloon catheter to improve blood flow through the valve. The procedure involves advancing a catheter with an inflatable balloon across the narrowed aortic valve and inflating the balloon to dilate the valve orifice.
Service Type: Percutaneous transcatheter valvular intervention
Typical Site of Service: Cardiac catheterization laboratory or interventional cardiology suite, often performed in an inpatient or outpatient hospital setting depending on clinical status and facility resources.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with symptomatic aortic stenosis presenting with exertional dyspnea, angina, syncope, or heart failure symptoms. The patient undergoes pre-procedure evaluation including transthoracic and/or transesophageal echocardiography demonstrating a calcified, stenotic aortic valve with elevated transvalvular gradients and aortic valve area consistent with severe or critical stenosis. Cardiology performs diagnostic coronary angiography to assess coronary anatomy when indicated. Balloon aortic valvuloplasty (92986) is scheduled in the cardiac catheterization laboratory under conscious sedation or general anesthesia when the clinical goal is transient hemodynamic improvement, bridge to definitive therapy (surgical aortic valve replacement or transcatheter aortic valve replacement), palliation in high-risk patients, or stabilization in cardiogenic shock.
Typical clinical workflow:
-
Pre-procedure: informed consent, review of echocardiography and angiography, anticoagulation and antiplatelet management, baseline labs.
-
Procedure: arterial access (commonly femoral), placement of a balloon aortic valvuloplasty catheter across the aortic valve under fluoroscopic and hemodynamic guidance, sequential balloon inflation(s) with hemodynamic assessment, and post-dilation monitoring. Temporary pacing may be used.
-
Post-procedure: vascular access closure, monitoring for complications (valve regurgitation, vascular injury, stroke), repeat echocardiography or hemodynamics to document gradient reduction, and disposition planning (same-day observation, short inpatient stay, or transfer for definitive valve therapy).
Typical site of service: hospital-based cardiac catheterization laboratory, cardiac catheterization suite, or hybrid operating room. Typical service type: interventional cardiology procedure.